{
    "paper_id": "d87e7692cec274b08ac144629659c741b6a59502",
    "metadata": {
        "title": "Impact of Kidney Transplantation on Humoral Immunity Against SARS-CoV-2: A Case Series From Belgium",
        "authors": [
            {
                "first": "Guillaume",
                "middle": [],
                "last": "Fernandes",
                "suffix": "",
                "affiliation": {
                    "laboratory": "",
                    "institution": "Saint Luc University Clinics",
                    "location": {
                        "settlement": "Brussels",
                        "country": "Belgium"
                    }
                },
                "email": ""
            },
            {
                "first": "Arnaud",
                "middle": [],
                "last": "Devresse",
                "suffix": "",
                "affiliation": {
                    "laboratory": "",
                    "institution": "Saint Luc University Clinics",
                    "location": {
                        "settlement": "Brussels",
                        "country": "Belgium"
                    }
                },
                "email": ""
            },
            {
                "first": "Anais",
                "middle": [],
                "last": "Scohy",
                "suffix": "",
                "affiliation": {
                    "laboratory": "",
                    "institution": "Saint Luc University Clinics",
                    "location": {
                        "settlement": "Brussels",
                        "country": "Belgium"
                    }
                },
                "email": ""
            },
            {
                "first": "Jean",
                "middle": [
                    "Cyr"
                ],
                "last": "Yombi",
                "suffix": "",
                "affiliation": {
                    "laboratory": "",
                    "institution": "Universit\u00e9 Catholique de Louvain",
                    "location": {
                        "settlement": "Brussels",
                        "country": "Belgium"
                    }
                },
                "email": ""
            },
            {
                "first": "Leila",
                "middle": [],
                "last": "Belkhir",
                "suffix": "",
                "affiliation": {
                    "laboratory": "",
                    "institution": "Universit\u00e9 Catholique de Louvain",
                    "location": {
                        "settlement": "Brussels",
                        "country": "Belgium"
                    }
                },
                "email": ""
            },
            {
                "first": "Julien",
                "middle": [],
                "last": "De Greef",
                "suffix": "",
                "affiliation": {
                    "laboratory": "",
                    "institution": "Universit\u00e9 Catholique de Louvain",
                    "location": {
                        "settlement": "Brussels",
                        "country": "Belgium"
                    }
                },
                "email": ""
            },
            {
                "first": "Martine",
                "middle": [],
                "last": "De Meyer",
                "suffix": "",
                "affiliation": {
                    "laboratory": "",
                    "institution": "Universit\u00e9 Catholique de Louvain",
                    "location": {
                        "settlement": "Brussels",
                        "country": "Belgium"
                    }
                },
                "email": ""
            },
            {
                "first": "Michel",
                "middle": [],
                "last": "Mourad",
                "suffix": "",
                "affiliation": {
                    "laboratory": "",
                    "institution": "Universit\u00e9 Catholique de Louvain",
                    "location": {
                        "settlement": "Brussels",
                        "country": "Belgium"
                    }
                },
                "email": ""
            },
            {
                "first": "Tom",
                "middle": [],
                "last": "Darius",
                "suffix": "",
                "affiliation": {
                    "laboratory": "",
                    "institution": "Universit\u00e9 Catholique de Louvain",
                    "location": {
                        "settlement": "Brussels",
                        "country": "Belgium"
                    }
                },
                "email": ""
            },
            {
                "first": "Antoine",
                "middle": [],
                "last": "Buemi",
                "suffix": "",
                "affiliation": {
                    "laboratory": "",
                    "institution": "Universit\u00e9 Catholique de Louvain",
                    "location": {
                        "settlement": "Brussels",
                        "country": "Belgium"
                    }
                },
                "email": ""
            },
            {
                "first": "Benoit",
                "middle": [],
                "last": "Kabamba",
                "suffix": "",
                "affiliation": {
                    "laboratory": "",
                    "institution": "Universit\u00e9 Catholique de Louvain",
                    "location": {
                        "settlement": "Brussels",
                        "country": "Belgium"
                    }
                },
                "email": ""
            },
            {
                "first": "Eric",
                "middle": [],
                "last": "Goffin",
                "suffix": "",
                "affiliation": {
                    "laboratory": "",
                    "institution": "Saint Luc University Clinics",
                    "location": {
                        "settlement": "Brussels",
                        "country": "Belgium"
                    }
                },
                "email": ""
            },
            {
                "first": "Nada",
                "middle": [],
                "last": "Kanaan",
                "suffix": "",
                "affiliation": {
                    "laboratory": "",
                    "institution": "Saint Luc University Clinics",
                    "location": {
                        "settlement": "Brussels",
                        "country": "Belgium"
                    }
                },
                "email": ""
            }
        ]
    },
    "abstract": [],
    "body_text": [
        {
            "text": "Guillaume Fernandes, MD, 1 Arnaud Devresse, PhD, 1,2 Anais Scohy, PharmD, 3 Jean Cyr Yombi, MD, 2, 4 Leila Belkhir, PhD, 2, 4 Julien De Greef, MD, 2, 4 Martine De Meyer, MD, 2,5 Michel Mourad, PhD, 2, 5 Tom Darius, PhD, 2,5 Antoine Buemi, MD, 2,5 Benoit Kabamba, MD, 2,4 Eric Goffin, MD, 1,2 and Nada Kanaan, MD 1,2 A nti-severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) vaccines have shown good efficacy in kidney transplant candidates 1 , contrasting with disappointing results in kidney transplant recipients (KTRs). 2 However, the impact of starting immunosuppressive treatments for KTRs on anti-SARS-CoV-2 humoral immunity has been poorly investigated to date.",
            "cite_spans": [
                {
                    "start": 74,
                    "end": 75,
                    "text": "3",
                    "ref_id": "BIBREF2"
                },
                {
                    "start": 96,
                    "end": 98,
                    "text": "2,",
                    "ref_id": "BIBREF1"
                },
                {
                    "start": 99,
                    "end": 100,
                    "text": "4",
                    "ref_id": "BIBREF3"
                },
                {
                    "start": 121,
                    "end": 123,
                    "text": "2,",
                    "ref_id": "BIBREF1"
                },
                {
                    "start": 124,
                    "end": 125,
                    "text": "4",
                    "ref_id": "BIBREF3"
                },
                {
                    "start": 147,
                    "end": 149,
                    "text": "2,",
                    "ref_id": "BIBREF1"
                },
                {
                    "start": 150,
                    "end": 151,
                    "text": "4",
                    "ref_id": "BIBREF3"
                },
                {
                    "start": 198,
                    "end": 200,
                    "text": "2,",
                    "ref_id": "BIBREF1"
                },
                {
                    "start": 201,
                    "end": 202,
                    "text": "5",
                    "ref_id": "BIBREF4"
                },
                {
                    "start": 532,
                    "end": 533,
                    "text": "2",
                    "ref_id": "BIBREF1"
                }
            ],
            "ref_spans": [],
            "section": "Impact of Kidney Transplantation on Humoral Immunity Against SARS-CoV-2: A Case Series From Belgium"
        },
        {
            "text": "We report the evolution of anti-SARS-CoV-2 antibody (Ab) titers in 14 KTRs, transplanted in our center between January 2021 and June 2021, who received at least 1 vaccine dose before KT. We assessed the anti-receptor-binding domain (RBD) Ab titers (Elecsys anti-SARS-CoV-2, Roche Diagnostics GmbH, Mannheim, Germany; positive threshold \u22650.8 U/mL) on the day of transplantation (day 0) and 28 d after (d 28). This work received an institutional review board approval.",
            "cite_spans": [],
            "ref_spans": [],
            "section": "Impact of Kidney Transplantation on Humoral Immunity Against SARS-CoV-2: A Case Series From Belgium"
        },
        {
            "text": "Ten patients had received their second dose of either the BNT162b2 (Pfizer-BioNTech, n = 8) or ChAdOx1 nCoV-19 vaccine (AstraZeneca, n = 2) with a mean time of 57 d (range, 25-78) before KT. Four patients had received a single dose of vaccine (Pfizer n = 2, AstraZeneca n = 2) with a mean time of 29 d (range, 15-30) before KT. The mean age was 58 y (range, 32-77) and 57% were male individuals. Twelve patients were on dialysis before transplantation with a mean duration of 54 mo (range, 20-122). One patient had a prior history of COVID-19.",
            "cite_spans": [],
            "ref_spans": [],
            "section": "Impact of Kidney Transplantation on Humoral Immunity Against SARS-CoV-2: A Case Series From Belgium"
        },
        {
            "text": "After KT, all patients were treated with an association of tacrolimus (trough levels, 10-13 ng/mL), mycophenolate (500 mg BID), and steroids. Sensitized patients (n = 3) and KTRs who received a graft from a living donor (n = 2) were additionally inducted with thymoglobulin and basiliximab, respectively. None of the patients developed COVID-19 after KT.",
            "cite_spans": [],
            "ref_spans": [],
            "section": "Impact of Kidney Transplantation on Humoral Immunity Against SARS-CoV-2: A Case Series From Belgium"
        },
        {
            "text": "On day 0, the mean anti-RBD Ab titer was high (mean \u00b1 SEM: 1124 \u00b1 441 U/mL). However, KTRs who had received a single dose of vaccine (n = 4) showed low mean Ab titer (0.83 \u00b1 0.43 U/mL). On day 28, we observed a significant decrease of anti-RBD Ab titers (Figure 1 ). However, Ab titers remained high (514 \u00b1 205 U/mL) compared with those reached in vaccinated KTRs that we previously published. 2 Not surprisingly, the 4 patients who had received a single dose of vaccine had low Ab titer on day 28 (2.85 \u00b1 1.84 U/mL). Interestingly, on day 28, anti-RBD Ab titers in patients inducted with thymoglobulin Letter to the Editor These results suggest that fully vaccinated patients maintain high Ab titers against SARS-CoV-2 in the first month post-KT, even in KTRs receiving induction therapy. It highlights the benefit to vaccinate all candidates before KT. 5 Other studies are required to assess the longterm evolution and the impact of other therapies used in KT (ie, rituximab) on anti-SARS-CoV-2 Ab acquired before KT.",
            "cite_spans": [
                {
                    "start": 394,
                    "end": 395,
                    "text": "2",
                    "ref_id": "BIBREF1"
                },
                {
                    "start": 855,
                    "end": 856,
                    "text": "5",
                    "ref_id": "BIBREF4"
                }
            ],
            "ref_spans": [
                {
                    "start": 254,
                    "end": 263,
                    "text": "(Figure 1",
                    "ref_id": "FIGREF0"
                }
            ],
            "section": "Impact of Kidney Transplantation on Humoral Immunity Against SARS-CoV-2: A Case Series From Belgium"
        }
    ],
    "bib_entries": {
        "BIBREF0": {
            "ref_id": "b0",
            "title": "High response rate to BNT162b2 mRNA COVID-19 vaccine among self-care dialysis patients",
            "authors": [
                {
                    "first": "H",
                    "middle": [],
                    "last": "Georgery",
                    "suffix": ""
                },
                {
                    "first": "A",
                    "middle": [],
                    "last": "Devresse",
                    "suffix": ""
                },
                {
                    "first": "J",
                    "middle": [
                        "C"
                    ],
                    "last": "Yombi",
                    "suffix": ""
                }
            ],
            "year": 2021,
            "venue": "Clin Kidney J",
            "volume": "14",
            "issn": "",
            "pages": "2129--2131",
            "other_ids": {}
        },
        "BIBREF1": {
            "ref_id": "b1",
            "title": "Disappointing immunization rate after two doses of the BNT162b2 vaccine in a Belgian cohort of kidney transplant recipients",
            "authors": [
                {
                    "first": "H",
                    "middle": [],
                    "last": "Georgery",
                    "suffix": ""
                },
                {
                    "first": "A",
                    "middle": [],
                    "last": "Devresse",
                    "suffix": ""
                },
                {
                    "first": "J",
                    "middle": [
                        "C"
                    ],
                    "last": "Yombi",
                    "suffix": ""
                }
            ],
            "year": 2021,
            "venue": "Transplantation",
            "volume": "105",
            "issn": "",
            "pages": "142--143",
            "other_ids": {}
        },
        "BIBREF2": {
            "ref_id": "b2",
            "title": "Persistent immunogenicity of the mRNA COVID-19 vaccine in patients vaccinated before kidney transplant",
            "authors": [
                {
                    "first": "S",
                    "middle": [
                        "G"
                    ],
                    "last": "Yi",
                    "suffix": ""
                },
                {
                    "first": "T",
                    "middle": [],
                    "last": "Eager",
                    "suffix": ""
                },
                {
                    "first": "L",
                    "middle": [],
                    "last": "Moore",
                    "suffix": ""
                }
            ],
            "year": 2021,
            "venue": "Transplantation",
            "volume": "105",
            "issn": "",
            "pages": "133--134",
            "other_ids": {}
        },
        "BIBREF3": {
            "ref_id": "b3",
            "title": "Immediate impact of induction treatment on post-vaccination SARS-Cov-2 serology in kidney transplant recipients",
            "authors": [
                {
                    "first": "I",
                    "middle": [],
                    "last": "Mohamadou",
                    "suffix": ""
                },
                {
                    "first": "J",
                    "middle": [],
                    "last": "Nkok",
                    "suffix": ""
                },
                {
                    "first": "P",
                    "middle": [],
                    "last": "Galichon",
                    "suffix": ""
                }
            ],
            "year": 2021,
            "venue": "Transplantation",
            "volume": "105",
            "issn": "",
            "pages": "135--136",
            "other_ids": {}
        },
        "BIBREF4": {
            "ref_id": "b4",
            "title": "COVID-19-related mortality during the first 60 days after kidney transplantation",
            "authors": [
                {
                    "first": "J",
                    "middle": [],
                    "last": "Pascual",
                    "suffix": ""
                },
                {
                    "first": "E",
                    "middle": [],
                    "last": "Melilli",
                    "suffix": ""
                },
                {
                    "first": "C",
                    "middle": [],
                    "last": "Jim\u00e9nez-Mart\u00edn",
                    "suffix": ""
                }
            ],
            "year": 2020,
            "venue": "Eur Urol",
            "volume": "78",
            "issn": "",
            "pages": "641--643",
            "other_ids": {}
        }
    },
    "ref_entries": {
        "FIGREF0": {
            "text": "Evolution of anti-RBD antibody titers. Mean \u00b1 SEM antibody titer on d 0 and d 28: 1124 \u00b1 441 U/mL and 514 \u00b1 205 U/mL (P = 0.003, Wilcoxon test). RBD, receptor-binding domain.",
            "latex": null,
            "type": "figure"
        },
        "FIGREF1": {
            "text": "titers remained high 15 d after KT in 7 patients (6 inducted with antithymocyte globulins and 1 with basiliximab) who had received 2 mRNA vaccine doses before transplantation.",
            "latex": null,
            "type": "figure"
        }
    },
    "back_matter": []
}